Navigation Links
Simple sea sponge helps scientists understand tissue rejection

Understanding why some transplant patients reject their new organs requires a working knowledge of how cells recognize and accept or reject each other. Xavier Fernndez-Busquets, an MBL researcher visiting from the University of Barcelona, has found the perfect ally in this quest: the red beard sea sponge, an Atlantic species that grows abundantly from just north of Cape Cod down to Florida.

The red beard sponge (Microciona prolifera) has a cell-to-cell recognition system that, on a basic level, is similar to that of humans but much simpler. It's also a good organism for laboratory research, since its cells and cell adhesion molecules can be isolated with simple, fast, and non-disruptive methods and studied, and because its fingerlike structures make grafting experiments relatively straightforward.

In experiments carried out on these sponges this summer, Dr. Fernndez-Busquets and his colleagues are studying the cells and molecules believed to be involved in the process of tissue rejection. By grafting together pieces of different individual sponges that will reject each other--a process that approximates what sometimes happens in human transplants--the scientists have observed that cells known as gray cells migrate to and amass at the graft site, a clear suggestion that they are involved in non-self tissue recognition and rejection. Researchers believe that gray cells may be a primitive form of our immune system's human killer cells.

Fernndez-Busquets has also been researching the role of the molecule called aggregation factor proteoglycan, which he has recently identified as another potential player in sponge tissue rejection reactions, and which is very easy to study in sponges. The human version of this molecule, which is different from the sponge version but similar in structure, is also believed to have important functions in cell-to-cell interactions, but is hard to study.

The ultimate goal of this research is to provide insights into the machinery behind human tissue rejection and immune responses in hopes of someday being able to control these processes and save lives.


'"/>

Source:Marine Biological Laboratory


Related biology news :

1. Simple drug has the potential to save many lives threatened by malaria
2. Discovery Promises Simpler Therapy for Sickle Cell Disease
3. Simple explanation for complex pattern of feather development
4. Simple idea to dramatically improve dengue vaccinations
5. Simple home spit test to spot deadly pre-eclampsia
6. Marine sponge yields nanoscale secrets
7. Hidden sponges determine coral reefs nutrient cycle
8. Jumping gene helps explain immune systems abilities
9. Protein helps regulate the genes of embryonic stem cells
10. Scientists reveal the shape of a protein that helps retroviruses break into cells
11. Thai spice helps cut blood sugar swings
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... MOINES, Iowa , Jan. 11, 2017 ... industry first with the release of its patent-pending calibration ... quickly and reliably perform calibrations, securely upload data logs ... flexibility for the customer. "Fighting drunk driving ... only for the public at large, but also for ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced ... "Digital Life Alliance" established by iCarbonX, the ... to build a "Global Digital Health Ecosystem that ... a combination of individual,s biological, behavioral and psychological ... agreement between the companies, SomaLogic will provide proteomics ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... ... 23, 2017 , ... Calvert Labs, Inc. announced today that ... Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. in Pharmacology ... an academic and industry preclinical drug developer spans more than three decades. ...
(Date:1/21/2017)... ... 20, 2017 , ... G&L Scientific Inc, a leading provider ... ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and ... This is the latest step in G&L’s expansion of its global clinical consulting ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/20/2017)... -- Stock-Callers.com explores the Biotech industry to ... recent performances of select equities. In this morning,s lineup ... Abeona Therapeutics Inc. (NASDAQ: ABEO ), Theravance ... Therapeutics Inc. (NASDAQ: SAGE ). According to ... market size is expected to reach $604.40 billion by 2020 due to ...
Breaking Biology Technology: